E-LIB Suche - Ergebnisse für: Krauwinkel, Walter

1

Pharmacokinetics and safety of brivaracetam in neonates wit..:

Pressler, Ronit ; Boylan, Geraldine ; Dempsey, Eugene...
Epilepsia Open. 9 (2024) 2 - p. 522-533 , 2024

Link: https://doi.org/10.1002/..

2

Brivaracetam exposure-response predictions in pediatric pat..:

Schoemaker, Rik ; Krauwinkel, Walter ; Elshoff, Jan-Peer.
Epilepsy Research. 202 (2024) - p. 107332 , 2024

Link: https://doi.org/10.1016/..

3

Pharmacokinetics, Safety, and Tolerability of Brivaracetam ..:

Stockis, Armel ; Nicolas, Jean‐Marie ; Sargentini‐Maier, Maria Laura.
Clinical Pharmacology in Drug Development. 12 (2023) 11 - p. 1121-1127 , 2023

Link: https://doi.org/10.1002/..

4

Pharmacokinetics, safety, and tolerability of intravenous b..:

Farkas, Mark Kristof ; Kang, Harriet ; Fogarasi, Andras...
Epilepsia. 63 (2022) 4 - p. 855-864 , 2022

Link: https://doi.org/10.1111/..

5

Pharmacokinetics of solifenacin in pediatric populations wi..:

Tannenbaum, Stacey ; den Adel, Martin ; Krauwinkel, Walter...
Pharmacology Research & Perspectives. 8 (2020) 6 - p. , 2020

Link: https://doi.org/10.1002/..

6

Safety, Pharmacokinetics, and Pharmacodynamics of ASP3662, ..:

Bellaire, Susan ; Walzer, Mark ; Wang, Tianli...
Clinical and Translational Science. 12 (2019) 3 - p. 291-301 , 2019

Link: https://doi.org/10.1111/..

7

Validation of LC–MS/MS methods for the determination of mir..:

Meijer, John ; van den Berg, Tom ; Huls, Robert...
Journal of Pharmaceutical and Biomedical Analysis. 167 (2019) - p. 155-160 , 2019

Link: https://doi.org/10.1016/..

8

Prediction of human CNS pharmacokinetics using a physiologi..:

Yamamoto, Yumi ; Välitalo, Pyry A. ; Wong, Yin Cheong...
European Journal of Pharmaceutical Sciences. 112 (2018) - p. 168-179 , 2018

Link: https://doi.org/10.1016/..

9

Predicting Drug Concentration‐Time Profiles in Multiple CNS..:

Yamamoto, Yumi ; Välitalo, Pyry A. ; Huntjens, Dymphy R....
CPT: Pharmacometrics & Systems Pharmacology. 6 (2017) 11 - p. 765-777 , 2017

Link: https://doi.org/10.1002/..

10

The variability in beta‐cell function in placebo‐treated su..:

Duong, Janna K. ; de Winter, Willem ; Choy, Steve...
British Journal of Clinical Pharmacology. 83 (2016) 3 - p. 487-497 , 2016

Link: https://doi.org/10.1111/..

11

Pharmacokinetic Interactions Between Mirabegron and Metform..:

Groen-Wijnberg, Monique ; van Dijk, Jan ; Krauwinkel, Walter...
European Journal of Drug Metabolism and Pharmacokinetics. 42 (2016) 3 - p. 417-429 , 2016

Link: https://doi.org/10.1007/..

12

A Generic Multi-Compartmental CNS Distribution Model Struct..:

Yamamoto, Yumi ; Välitalo, Pyry A. ; van den Berg, Dirk-Jan...
Pharmaceutical Research. 34 (2016) 2 - p. 333-351 , 2016

Link: https://doi.org/10.1007/..

13

Clinical Pharmacokinetic Studies of Enzalutamide:

Gibbons, Jacqueline A. ; Ouatas, Taoufik ; Krauwinkel, Walter...
Clinical Pharmacokinetics. 54 (2015) 10 - p. 1043-1055 , 2015

Link: https://doi.org/10.1007/..

14

Pharmacokinetic Drug Interaction Studies with Enzalutamide:

Gibbons, Jacqueline A. ; de Vries, Michiel ; Krauwinkel, Walter...
Clinical Pharmacokinetics. 54 (2015) 10 - p. 1057-1069 , 2015

Link: https://doi.org/10.1007/..

15

Clinical Pharmacokinetics and Pharmacodynamics of the Novel..:

Kadokura, Takeshi ; Zhang, Wenhui ; Krauwinkel, Walter...
Clinical Pharmacokinetics. 53 (2014) 11 - p. 975-988 , 2014

Link: https://doi.org/10.1007/..